Home › Acute Myeloid Leukemia › Tennessee › Knoxville

Acute Myeloid Leukemia clinical trials in Knoxville, TN

4 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Knoxville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

RecruitingPhase 3

University of Tennessee, Knoxville

Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3

East Tennessee Childrens Hospital, Knoxville

6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

RecruitingPhase 3

East Tennessee Childrens Hospital, Knoxville

Ages 1 to 25 · All sexes · Updated Sep 4, 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RecruitingPhase 1/2

East Tennessee Childrens Hospital, Knoxville

Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Knoxville

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.